邦特 4107
OTC · Biotechnology and medical care107.5▲+1.5 (+1.42%)After close
- Prev close
- 106
- Volume (shares)
- 79,000
- Data time
- 2026-11-11 13:30:00
- Open
- 107.00
- High
- 108.00
- Low
- 106.00
- Prev close
- 106.00
- Volume (lots)
- 79
- Turnover
- 0.08 億
- P/E
- 12.6
- Cash yield
- 5.12%
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.48% | 45.21% | 44.65% | 45.27% | 42.22% | 43.33% | 45.83% | 45.37% |
| Operating margin | 33.35% | 32.21% | 31.80% | 32.43% | 30.62% | 30.68% | 32.33% | 34.00% |
| Net margin | 25.89% | 26.53% | 27.43% | 26.31% | 21.20% | 25.94% | 26.62% | 25.99% |
| ROE (TTM) | 17.29% | 16.61% | 15.30% | 15.40% | 16.29% | 17.15% | 15.93% | 15.64% |
| ROA (TTM) | 12.24% | 11.48% | 11.59% | 11.53% | 10.95% | 11.28% | 11.40% | 11.11% |
| EPS, quarter (TWD) | 2.20 | 2.09 | 2.24 | 1.98 | 1.62 | 1.94 | 1.93 | 2.08 |
| EPS, TTM (TWD) | 8.51 | 7.93 | 7.78 | 7.47 | 7.57 | 7.75 | 7.62 | 7.21 |
| Month | Revenue | MoM | YoY | YTD | YTD YoY |
|---|---|---|---|---|---|
| 2026-10 | 2.0 | 2.75% | 2.45% | 19.2 | 8.64% |
| 2026-09 | 2.0 | 1.42% | 10.40% | 17.2 | 9.41% |
| 2026-08 | 1.9 | -0.04% | 17.36% | 15.2 | 9.28% |
| 2026-07 | 1.9 | -2.20% | 8.45% | 13.3 | 8.20% |
| 2026-06 | 2.0 | -0.05% | 12.23% | 11.3 | 8.16% |
| 2026-05 | 2.0 | 1.88% | 14.25% | 9.4 | 7.34% |
| 2026-04 | 1.9 | -0.25% | 6.39% | 7.4 | 5.64% |
| 2026-03 | 1.9 | 20.14% | 11.67% | 5.5 | 5.38% |
| 2026-02 | 1.6 | -15.24% | -12.69% | 3.5 | 2.20% |
| 2026-01 | 1.9 | 0.54% | 19.46% | 1.9 | 19.46% |
| 2025-12 | 1.9 | 4.53% | 19.65% | 21.4 | 3.03% |
| 2025-11 | 1.8 | -7.49% | 2.74% | 19.5 | 1.66% |
Revenue in NT$100M; 12 months per page.
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.9 | 5.5 | 5.7 | 5.2 | 5.3 | 5.2 | 5.0 | 5.5 |
| Cost of revenue | 3.2 | 3.0 | 3.1 | 2.8 | 3.1 | 2.9 | 2.7 | 3.0 |
| Gross profit | 2.7 | 2.5 | 2.5 | 2.4 | 2.2 | 2.2 | 2.3 | 2.5 |
| Operating expenses | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.7 | 0.7 | 0.6 |
| Operating income | 2.0 | 1.8 | 1.8 | 1.7 | 1.6 | 1.6 | 1.6 | 1.9 |
| Non-operating items | 0.0 | 0.1 | 0.1 | 0.1 | -0.3 | 0.1 | 0.1 | -0.0 |
| Pre-tax income | 2.0 | 1.8 | 1.9 | 1.8 | 1.3 | 1.7 | 1.8 | 1.8 |
| Income tax | 0.5 | 0.4 | 0.4 | 0.4 | 0.2 | 0.4 | 0.4 | 0.4 |
| Continuing operations | 1.5 | 1.4 | 1.6 | 1.4 | 1.1 | 1.3 | 1.3 | 1.4 |
| Net income | 1.5 | 1.4 | 1.6 | 1.4 | 1.1 | 1.3 | 1.3 | 1.4 |
| Net income to parent | 1.5 | 1.4 | 1.6 | 1.4 | 1.1 | 1.3 | 1.3 | 1.4 |
| Other comprehensive income | -0.0 | 0.1 | 0.2 | 0.1 | -0.6 | 0.1 | 0.2 | -0.1 |
| Total comprehensive income | 1.5 | 1.5 | 1.7 | 1.5 | 0.5 | 1.4 | 1.5 | 1.3 |
| EPS (TWD) | 2.20 | 2.09 | 2.24 | 1.98 | 1.62 | 1.94 | 1.93 | 2.08 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current assets | 25.6 | 24.6 | 23.3 | 21.5 | 24.0 | 23.6 | 22.2 | 20.5 |
| Non-current assets | 23.2 | 23.5 | 23.3 | 23.4 | 23.5 | 24.1 | 24.3 | 24.4 |
| Total assets | 48.8 | 48.1 | 46.6 | 44.9 | 47.5 | 47.7 | 46.5 | 44.9 |
| Current liabilities | 9.3 | 9.7 | 5.5 | 5.2 | 8.9 | 9.4 | 5.7 | 5.3 |
| Non-current liabilities | 4.2 | 4.5 | 5.1 | 5.3 | 5.7 | 5.9 | 6.4 | 6.7 |
| Total liabilities | 13.5 | 14.3 | 10.5 | 10.6 | 14.6 | 15.4 | 12.0 | 12.0 |
| Share capital | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 |
| Capital surplus | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 |
| Retained earnings | 24.9 | 23.4 | 25.8 | 24.2 | 22.9 | 21.7 | 23.9 | 22.5 |
| Other equity | 0.2 | 0.3 | 0.2 | 0.0 | -0.1 | 0.5 | 0.4 | 0.3 |
| Equity to parent | 35.3 | 33.8 | 36.1 | 34.4 | 32.9 | 32.4 | 34.4 | 32.9 |
| Total equity | 35.3 | 33.8 | 36.1 | 34.4 | 32.9 | 32.4 | 34.4 | 32.9 |
| Book value per share (TWD) | 50.91 | 48.77 | 52.05 | 49.57 | 47.48 | 46.71 | 49.65 | 47.45 |
Amounts in NT$100M (per-share items in NT$).
| Item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.3 | 2.5 | 2.1 | 1.2 | 1.3 | 2.1 | 2.3 | 1.3 |
| Investing cash flow | -2.5 | -1.6 | -0.1 | 0.3 | -0.6 | -1.7 | -2.8 | 0.2 |
| Financing cash flow | -0.3 | -0.7 | -0.4 | -3.9 | -0.4 | -0.4 | -0.4 | -3.6 |
| FX effect | -0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | -0.0 |
| Net change in cash | -1.6 | 0.3 | 1.6 | -2.4 | 0.1 | -0.0 | -0.8 | -2.2 |
| Cash, beginning | 11.6 | 11.6 | 12.4 | 12.4 | 12.4 | 12.4 | 13.5 | 13.5 |
| Cash, ending | 10.3 | 11.9 | 11.6 | 10.0 | 12.4 | 12.4 | 12.4 | 13.2 |
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 274.68% | — | — | — | — | — | — | — |
| Debt ratio | 27.72% | 29.68% | 22.59% | 23.52% | 30.70% | 32.19% | 25.93% | 26.80% |
| Equity ratio | 72.28% | 70.32% | 77.41% | 76.48% | 69.30% | 67.81% | 74.07% | 73.20% |
| Equity multiplier | 1.38 | 1.42 | 1.29 | 1.31 | 1.44 | 1.47 | 1.35 | 1.37 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.46 | 0.45 | 0.46 | 0.46 | 0.44 | 0.44 | 0.45 | 0.46 |
| Equity turnover | 0.65 | 0.65 | 0.61 | 0.62 | 0.65 | 0.67 | 0.63 | 0.65 |
Source: MOPS. For reference only; not investment advice.